Upgrade to SI Premium - Free Trial

vTv Therapeutics (VTVT) Tops Q1 EPS by 5c

May 11, 2023 5:53 PM

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

Categories

Earnings